1,073 research outputs found

    Effects of ergo-nutritional strategies on recovery in combat sports disciplines

    Get PDF
    [EN] Introduccion: Para mejorar el proceso de recuperacion en las disciplinas deportivas de combate, las estrategias ergo-nutricionales son una opcion eficaz en el entrenamiento y la competicion. Algunas de estas alternativas mejoran el rendimiento, pero actualmente existe una escasa bibliografia con resultados controvertidos relacionados con el efecto de recuperacion. Esta revision sistematica tuvo como objetivo determinar que estrategias ergo-nutricionales son mas efectivas en los procesos de recuperacion. Se llevo a cabo siguiendo las pautas Preferred Reporting Items for Systematic Review (PRISMA). Se realizo una busqueda computarizada en PubMed, Web of Science, Cochrane Collaboration Database, Evidence Database, Evidence Based Medicine Search review, National Guidelines, EM-BASE, Scopus y el sistema Google Scholar (desde 1995 hasta el 30 de abril de 2021). Se utilizo el modelo PICOS para definir los criterios de inclusion y exclusion. De los 123 estudios encontrados inicialmente, 18 cumplieron los criterios de elegibilidad y fueron incluidos. Se examinaron datos de 367 atletas de diferentes disciplinas. La evidencia se agrupo en 4 areas: estres oxidativo, recuperacion muscular y energetica, reparacion muscular y acidosis metabolica. La evidencia mostro que las vitaminas, los minerales y algunos productos ergo-nutricionales naturales son eficaces como antioxidantes, los hidratos de carbono y las proteinas determinan su efecto recuperador y el bicarbonato de sodio es el principal retardador metabolico de la acidosis. Se destaca la importancia de aceptar un plan ergo-nutricional para mejorar el proceso de recuperacion. A pesar de ello, y teniendo en cuenta los efectos descritos en la literatura, se necesitan mas estudios para reforzar la evidencia actual. Abstract Introduction: In order to improve the recovery process in combat sports disciplines, ergo-nutritional strategies could be an effective option in training and competition. Some of these ergo-nutritional aids could improve performance but literature references are scarce, with controversial results regarding actual recovery effects. This systematic review aimed to examine which ergo-nutritional methods are most effective for assisting in the recovery process in combat sports, and to determine the appropriate training stimuli. This systematic review was carried out following the Preferred Reporting Items for Systematic Review (PRISMA) guidelines. A computerized search was performed in PubMed, Web of Science, the Cochrane Collaboration Database, Evidence Database, Evidence Based Medicine Search review, National Guidelines, EM-BASE, Scopus and Google Scholar system (from 1995 to April 30, 2021). The PICOS model was used to define inclusion and exclusion criteria. Out of 123 studies initially found, 18 met the eligibility criteria and were included in the review. Data from 367 athletes from different disciplines were examined. The evidence was grouped in 4 areas: oxidative stress, muscle and energy recovery, muscle repair, and metabolic acidosis. Evidence showed that vitamins, minerals, and some natural ergo-nutritional products are effective as antioxidants. Carbohydrates and protein determine the recovery effect. Sodium bicarbonate has a role as primary acidosis metabolic delayer. Accordingly, ergo-nutritional aids can help in the recovery process. Considering the effects outlined in the literature, more studies are needed to provide firm evidence

    49- #1023 UBICACIÓN ÓPTIMA DE GENERACIÓN 57 DISTRIBUIDA MEDIANTE INDICES NODALES PONDERADOS DE ALIVIO DE CARGA EN TRANSMISIÓN USANDO PSO

    Get PDF
    En este artículo se presenta una metodología para laubicación óptima de generación distribuida (GD) ensistemas de potencia usando como métrica los índicesnodales ponderados de alivio de carga en transmisión(WTLR por sus siglas en inglés). Estos índices sonusados para evaluar el nivel de seguridad de unsistema de potencia ante contingencias N-1. Además, los WTLR indican en que nodos se debe inyectarpotencia para reducir sobrecargas bajo operaciónnormal y en contingencia. Los valores de estos índicesse utilizan para determinar nodos candidatos dondeubicar GD; esta última se modela como una inyecciónde potencia negativa en las barras donde es ubicada.Para guiar la ubicación de la GD se utiliza lametaheurística PSO (Particle Swarm Optimization). Lametodología propuesta se valida en un prototiporepresentativo del sistema de potencia colombiano de93 barras. Los resultados muestran que la ubicaciónestratégica de DG tiene un impacto positivo en laseguridad del sistema de prueba

    Long-Term Clinical Outcomes of Treatment with Dental Implants with Acid Etched Surface

    Get PDF
    Implant dentistry constitutes a therapeutic modality in the prosthodontic treatment of partially and totally edentulous patients. This study reports a long-term evaluation of treatment by the early loading of acid-etched surface implants. Forty-eight partially and totally edentulous patients were treated with 169 TSA Defcon® acid-etched surface implants for prosthodontic rehabilitation. Implants were loaded after a healing free-loading period of 6–8 weeks in mandible and maxilla, respectively. Implant and prosthodontic clinical findings were followed during at least 17 years. Clinical results indicate a survival and success rate of implants of 92.9%, demonstrating that acid-etched surface achieves and maintains successful osseointegration. Five implants in three patients were lost during the healing period. Sixty-five prostheses were placed in 45 patients over the remaining 164 implants, 30 single crowns, 21 partially fixed bridges, 9 overdentures, and 5 full-arch fixed rehabilitations. A total of 12 implants were lost during the follow-up period. Mean marginal bone loss was 1.91 ± 1.24 mm, ranging from 1.1 to 3.6 mm. The most frequent complication was prosthetic technical complications (14.2%), followed by peri-implantitis (10.6%). The mean follow-up was of 214.4 months (208–228 months). Prosthodontic rehabilitation with an early-loading protocol over acid-etched surface implants is a successful implant treatmen

    Regulation of mycorrhizal colonization under stress in tomato depends on symbiotic efficiency

    Get PDF
    The mutualistic symbiosis between plants and arbuscular mycorrhizal (AM) fungi is based on a balanced nutrient exchange between both partners, with the plant achieving improved nutrition and stress tolerance. The symbiosis is finely-tuned according to plant’s needs and surrounding conditions, usually through phytohormonal signaling. Thus, environmental conditions or stress factors modulating phytohormone signaling may influence the symbiosis. This study compares the colonization abilities of 2 AM fungal species, Funneliformis mosseae and Rhizophagus irregularis, independently or in combination, in tomato plants subjected to different stress conditions. These included salt stress and systemic defense activation by aboveground application of the defense-related hormones methyl jasmonate, abscisic acid and salicylic acid. The results show that root colonization by the two fungal species differs depending on the stress treatment. Nutrient and transcriptional analyses revealed that changes in colonization correlated with differential regulation of nutrient exchange, plant defensive responses, and symbiosis regulatory genes. Specifically, under salt stress R. irregularis colonization decreased, while F. mosseae colonization was promoted. These differential regulation of colonization under stress positively correlated with changes in the functionality of the symbiosis. Overall, the results support that the benefits provided by each AM fungi influence carbon reward and determines the control of root colonization by the host plant.RTI2018-094350-B-C31 and PID2021-124813OB-C31 from the Spanish National R&D Plan of the Ministry of ScienceInnovation and Universities (MICIUEuropean Regional Development Fund (ERDF) ‘a way a making Europ

    Hypervitaminosis D has no positive effects on goat tuberculosis and may cause chronic renal lesions

    Get PDF
    [Background]: There is evidence for a link between vitamin D deficiency and active tuberculosis (TB). In human beings, several trials have evaluated the role of vitamin D supplementation in TB treatment with conflicting results. However, the role of vitamin D supplementation in animal TB control has received less attention. The authors evaluated the benefit of vitamin D supplementation for preventing mycobacterial infection or reducing TB lesions (TBL) in a controlled trial with goats naturally exposed to Mycobacterium caprae. [Methods]: Two groups of goats, a vitamin D-supplemented group and a non-supplemented control group, were housed for 10 months in direct contact with M caprae-infected adult goats. Upon contact with the infected adult goats, all animals were TB-tested every two months. [Results]: No experimental evidence of a protective effect of vitamin D supplementation based on M caprae culture prevalence, TBL prevalence, median TBL score or the proportion of single versus multiple organs presenting TBL was observed. [Conclusion]: The results indicate that, in the conditions used in this study, vitamin D supplementation in goats does not reduce TB infection risk nor the diffusion and severity of TBL. In addition, vitamin D-supplemented goats presented hyperphosphataemia and renal injury with calcifications suggestive of vitamin D intoxication.This work was supported by the Ministerio de Economía, Industria y Competitividad of Spain (RTC-2016-4746-2) and the Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria of Spain (RTA2015-00043-C02-02). AR is the recipient of an Industrial Doctorate contract (DI-15-08110) and JB holds a ‘Juan de la Cierva program’ contract (IJCI-2015-24805), both funded by the Spanish Ministry of Science, Innovation and Universities

    Self Assembly of semiconductor nanostructures

    Get PDF
     Abstract In this work we present the growth and characterization of GaAs self-assembled quantum wires (SAQWRs), and InAs self-assembled quantum dots (SAQDs) by molecular beam epitaxy on (631)-oriented GaAs substrates. Adatoms on the (631) crystal plane present a strong surface diffusion anisotropy which we use to induce preferential growth along one direction to produce SAQWRs. On the other hand, InAs SAQDs were obtained on GaAs(631) with SAQWRs by the Stransky–Krastanov (S-K) growth method. SAQDs grown directly on (631) substrates presented considerable fluctuations in size. We study the effects of growing a stressor layer before the SAQDs formation to reduce these fluctuations.Keywords : Quantum wires, quantum dots; selfassembly; molecular beam epitaxy

    Cloroquina e hidroxicloroquina en el manejo del COVID-19: una revisión

    Get PDF
    Due to the new coronavirus (SARS-CoV-2) pandemic, health authorities of some of the most affected countries implemented the emerging use of chloroquine and hydroxychloroquine for the management of COVID-19 (associated disease). Nevertheless, the clinical benefits of such drugs have not yet been fully elucidated. To assess the safety, efficacy, and prophylactic use of chloroquine and its derivatives in the clinical management of COVID-19, a literature search of the databases was conducted through Pubmed, The Cochrane Library, Embase, and Lilacs from November 2019 until June 7th, 2020. The reviewers independently and in duplicate selected studies for inclusion and assessment of risk of bias. Thirteen studies were included: seven cohorts, five randomized clinical trials and one non-randomized clinical trial. Four studies reported clinical benefits of using chloroquine or hydroxychloroquine alone or in combination with macrolides for the treatment of COVID-19, eight studies reported an increased risk of life-threatening adverse effects due to the use of either drug, and one study did not report any benefit for prophylaxis. The urgent need for studies evaluating the safety and clinical efficacy of chloroquine and its derivatives in the management of COVID-19 is highlighted.Debido a la pandemia por el nuevo coronavirus (SARS-CoV-2), las autoridades sanitarias de algunos de los países más afectados implementaron el uso emergente de cloroquina e hidroxicloroquina para el manejo del COVID-19 (enfermedad asociada). Sin embargo, los beneficios clínicos de dichos fármacos aún no han sido dilucidados por completo. Para evaluar la seguridad, la eficacia y el uso profiláctico de cloroquina y sus derivados en el manejo clínico de COVID-19, se realizó una búsqueda bibliográfica en las bases de datos: Pubmed, The Cochrane Library, Embase y Lilacs desde noviembre del 2019 hasta el 07 de junio del 2020. Los revisores de forma independiente y en duplicado seleccionaron estudios para su inclusión y evaluación del riesgo de sesgos. Se incluyeron 13 estudios: siete cohortes, cinco ensayos clínicos aleatorizados y un ensayo clínico no aleatorizado. Cuatro estudios reportaron beneficios clínicos del uso de cloroquina o hidroxicloroquina sola o en combinación con macrólidos para el tratamiento del COVID-19, ocho estudios reportaron mayor riesgo de efectos adversos potencialmente mortales debido al uso de cualquiera de los dos fármacos y un estudio no reportó ningún beneficio para la profilaxis. Se destaca la necesidad urgente de estudios que evalúen la seguridad y eficacia clínica de cloroquina y sus derivados en el manejo del COVID-19

    Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry

    Get PDF
    Purpose The monarchE trial showed that the addition of abemaciclib improves efficacy in patients with high-risk early breast cancer (EBC). We analyzed the long-term outcomes of a population similar to the monarchE trial to put into context the potential benefit of abemaciclib. Methods HR-positive/HER2-negative EBC patients eligible for the monarchE study were selected from 3 adjuvant clinical trials and a breast cancer registry. Patients with ≥ 4 positive axillary lymph nodes (N +) or 1–3 N + with tumor size ≥ 5 cm and/or histologic grade 3 and/or Ki67 ≥ 20%, who had undergone surgery with curative intent and had received anthracyclines ± taxanes and endocrine therapy in the neoadjuvant and /or adjuvant setting were included. We performed analysis of Invasive Disease-Free Survival (iDFS), Distant Disease-Free Survival (dDFS) and Overall Survival (OS) at 5 and 10 years, as well as yearly (up to 10) of Invasive Relapse Rate (IRR), Distant Relapse Rate (DRR) and Death Rate (DR). Results A total of 1,617 patients were analyzed from the GEICAM-9906 (312), GEICAM-2003–10 (210), and GEICAM-2006–10 (160) trials plus 935 from El Álamo IV. With a median follow-up of 10.1 years, the 5 and 10 years iDFS rates were 75.2% and 57.0%, respectively. The dDFS and OS rates at 5 years were 77.4% and 88.8% and the respective figures at 10 years were 59.7% and 70.9%. Conclusions This data points out the need for new therapies for those patients. A longer follow-up of the monarchE study to see the real final benefit with abemaciclib is warranted

    Dopaminergic control of ADAMTS2 expression through cAMP/CREB and ERK: molecular effects of antipsychotics

    Get PDF
    A better understanding of the molecular mechanisms that participate in the development and clinical manifestations of schizophrenia can lead to improve our ability to diagnose and treat this disease. Previous data strongly associated the levels of deregulated ADAMTS2 expression in peripheral blood mononuclear cells (PBMCs) from patients at first episode of psychosis (up) as well as in clinical responders to treatment with antipsychotic drugs (down). In this current work, we performed an independent validation of such data and studied the mechanisms implicated in the control of ADAMTS2 gene expression. Using a new cohort of drug-naïve schizophrenia patients with clinical follow-up, we confirmed that the expression of ADAMTS2 was highly upregulated in PBMCs at the onset (drug-naïve patients) and downregulated, in clinical responders, after treatment with antipsychotics. Mechanistically, ADAMTS2 expression was activated by dopaminergic signalling (D1-class receptors) and downstream by cAMP/CREB and mitogen-activated protein kinase (MAPK)/ERK signalling. Incubation with antipsychotic drugs and selective PKA and MEK inhibitors abrogated D1-mediated activation of ADAMTS2 in neuronal-like cells. Thus, D1 receptors signalling towards CREB activation might participate in the onset and clinical responses to therapy in schizophrenia patients, by controlling ADAMTS2 expression and activity. The unbiased investigation of molecular mechanisms triggered by antipsychotic drugs may provide a new landscape of novel targets potentially associated with clinical efficacy.Acknowledgements: We are highly indebted to the participants and their families for their cooperation in this study. We also thank IDIVAL biobank (Inés Santiuste and Jana Arozamena) for clinical samples and data as well as the PAFIP members (Marga Corredera) for the data collection. This work was supported by: SAF2016-76046-R and SAF2013-46292-R (MINECO and FEDER) to B.C.F., PI16/00156 (isciii and FEDER) to J.P.V., LUCHAMOS POR LA VIDA project to F.R.J. and J.P.V., SAF2017-83702-R (MINECO and FEDER), Red TERCEL RD12/0019/0024 (ISCIII) and GVA-PROMETEO 2018/041 (Generalitat Valenciana) to S.M. J.P.V. is supported by the RyC research programme (RYC-2013-14097) and F.R.J. by the predoctoral research programme (BES-2014-070615), from MINECO and FEDER
    corecore